![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
57 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) All CancerCare Connect Education Workshops
-
- Health & Fitness
- Review of Chronic Lymphocytic Leukemia
- Significant Role of Testing in Informing Treatment Choices
- First-Line Treatment Options
- Treatment for Relapsed & Refractory CLL
- Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments
- Current Perspectives on New & Emerging Treatments of CLL
- Updates on Clinical Trials & Their Significance for CLL
- Key Questions to Ask & Re-Ask Your CLL Health Care Team
- Practical & Psychosocial Support to Cope with CLL
- Questions for Our Panel of Experts
- Review of Chronic Lymphocytic Leukemia
- Significant Role of Testing in Informing Treatment Choices
- First-Line Treatment Options
- Treatment for Relapsed & Refractory CLL
- Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments
- Current Perspectives on New & Emerging Treatments of CLL
- Updates on Clinical Trials & Their Significance for CLL
- Key Questions to Ask & Re-Ask Your CLL Health Care Team
- Practical & Psychosocial Support to Cope with CLL
- Questions for Our Panel of Experts
57 min